Ignite Creation Date:
2024-05-06 @ 12:44 PM
Last Modification Date:
2024-10-26 @ 1:03 PM
Study NCT ID:
NCT03832621
Status:
COMPLETED
Last Update Posted:
2022-04-04
First Post:
2019-01-31
Brief Title:
NIVOLUMAB Plus IPILIMUMAB and TEMOZOLOMIDE in Microsatellite Stable MGMT Silenced Metastatic Colorectal Cancer
Sponsor:
Fondazione IRCCS Istituto Nazionale dei Tumori Milano
Organization:
Fondazione IRCCS Istituto Nazionale dei Tumori Milano
Organization Data
Organization:
Fondazione IRCCS Istituto Nazionale dei Tumori Milano
Class:
OTHER
Study ID:
INT202-18
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Fondazione IRCCS Istituto Nazionale dei Tumori Milano
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None